Clinical Trial

STarting incrEmental Prescription of Peritoneal Dialysis

Study acronym: STEP-PD
Recruiting
View on ClinicalTrials.gov →
Summary
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Protocol Amendment History 1 change
notable Trial sites expanded: 6 -> 9 locations 2026-06-19
Trial Details
NCT Number NCT06642597
Lead Sponsor The University of Queensland
Conditions Peritoneal Dialysis (PD), Kidney Failure
Enrollment 224 participants
Start Date 2025-09-19
Primary Completion 2029-09-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18